Cim Investment Management Inc Acadia Pharmaceuticals Inc Transaction History
Cim Investment Management Inc
- $321 Million
- Q2 2024
A detailed history of Cim Investment Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Cim Investment Management Inc holds 15,082 shares of ACAD stock, worth $242,367. This represents 0.08% of its overall portfolio holdings.
Number of Shares
15,082
Previous 18,670
19.22%
Holding current value
$242,367
Previous $345,000
28.99%
% of portfolio
0.08%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding ACAD
# of Institutions
288Shares Held
161MCall Options Held
723KPut Options Held
257K-
Baker Bros. Advisors LP New York, NY42.9MShares$689 Million9.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$220 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$220 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$194 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$93.2 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.6B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...